Controversies on lung cancers manifesting as part-solid nodules

European Radiology

Volumn 28, Issue 2, 2018, Pages 747-759

  Yip, Rowena ^a   Li, Kunwei ^a,b   Liu, Li ^a,c   Xu, Dongming ^a   Tam, Kathleen ^a   Yankelevitz, David F ^a   Taioli, Emanuela ^a   Becker, Betsy ^d   Henschke, Claudia I ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b THE FIFTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c PEKING UNION MEDICAL COLLEGE   (China)

^d FLORIDA STATE UNIVERSITY   (United States)

Author keywords

Ground glass; Lymph node metastases; Staging; Subsolid nodules; Survival

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER SPECIFIC SURVIVAL; CANCER SURVIVAL; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; LUNG CANCER; LUNG NODULE; OVERALL SURVIVAL; PART SOLID NODULE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SURVIVAL RATE; SYSTEMATIC REVIEW; ADENOCARCINOMA; DIAGNOSTIC IMAGING; MORTALITY; MULTIPLE PULMONARY NODULES; PATHOLOGY; RETROSPECTIVE STUDY; X-RAY COMPUTED TOMOGRAPHY;

ADENOCARCINOMA; DISEASE-FREE SURVIVAL; HUMANS; MULTIPLE PULMONARY NODULES; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85027982843     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-017-4975-9     Document Type: Article

References (96)

1. Yankelevitz DF, Yip R, Smith JP, Liang M, Liu Y, Xu DM et al (2015) CT screening for lung cancer: nonsolid nodules in baseline and annual repeat rounds. Radiology 277(2):555–564
2. Yip R, Yankelevitz DF, Hu M, Li K, Xu DM, Jirapatnakul A et al (2016) Lung cancer deaths in the National Lung Screening Trial attributed to nonsolid nodules. Radiology 281(2):589–596
3. Yip R, Wolf A, Tam K, Taioli E, Olkin I, Flores R et al (2016) Outcomes of lung cancers manifesting as nonsolid nodules. Lung Cancer 97:35–42
4. Henschke CI, Yip R, Smith JP, Wolf AS, Flores RM, Liang M et al (2016) CT screening for lung cancer: part-solid nodules in baseline and annual repeat rounds. AJR Am J Roentgenol 207(6):1176–1184
5. Yip R, Yankelevitz D, Li K, Xu D, Jirapatnakul A, Henschke C (2016) Lung cancer deaths in the National Lung Screening Trial attributed to cancers manifesting as part-solid nodules. AJR Am J Roentgenol. doi:10.2214/ajr.16.16930
6. Noguchi M, Morikawa A, Kawasaki M, Matsuno Y, Yamada T, Hirohashi S et al (1995) Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 75(12):2844–2852
7. Noguchi M, Shimosato Y (1995) The development and progression of adenocarcinoma of the lung. Cancer Treat Res 72:131–142
8. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger K, Yatabe Y et al (2011) International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. Proc Am Thorac Soc 8(5):381–385
9. Travis W, Brambilla E, Burke A, Marx A, Nicholson A (2015) WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart, 4th edn. International Agency for Research on Cancer, Lyon
10. Travis WD, Asamura H, Bankier AA, Beasley MB, Detterbeck F, Flieder DB et al (2016) The IASLC Lung Cancer Staging Project: proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming Eighth Edition of the TNM Classification of Lung Cancer. J Thorac Oncol 11(8):1204–1223
11. Kuriyama K, Seto M, Kasugai T, Higashiyama M, Kido S, Sawai Y et al (1999) Ground-glass opacity on thin-section CT: value in differentiating subtypes of adenocarcinoma of the lung. AJR Am J Roentgenol 173(2):465–469
12. Henschke C, Yankelevitz D, Mirtcheva R, McGuinness G, McCauley D, Miettinen O (2002) CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol 178(5):1053–1057
13. Sone S, Nakayama T, Honda T, Tsushima K, Li F, Haniuda M et al (2007) Long-term follow-up study of a population-based 1996-1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography. Lung Cancer 58(3):329–341
14. Hasegawa M, Sone S, Takashima S, Li F, Yang ZG, Maruyama Y et al (2000) Growth rate of small lung cancers detected on mass CT screening. Br J Radiol 73(876):1252–1259
15. Naidich DP, Bankier AA, MacMahon H, Schaefer-Prokop CM, Pistolesi M, Goo JM et al (2013) Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology 266(1):304–317
16. MacMahon H, Naidich DP, Goo JM, Lee KS, Leung AN, Mayo JR et al (2017) Guidelines for management of incidental pulmonary nodules detected on CT images: From the Fleischner Society 2017. Radiology 161659
17. Callister ME, Baldwin DR, Akram AR, Barnard S, Cane P, Draffan J et al (2015) British Thoracic Society guidelines for the investigation and management of pulmonary nodules. Thorax 70(Suppl 2):ii1–ii54
18. Miettinen OS, Henschke CI, Smith JP, Yankelevitz DF (2014) Is ground glass descriptive of a type of pulmonary nodule? Radiology 270(1):311–312
19. Sugi K, Kobayashi S, Sudou M, Sakano H, Matsuda E, Okabe K (2010) Long-term prognosis of video-assisted limited surgery for early lung cancer. Eur J Cardiothorac Surg 37(2):456–460
20. Matsuguma H, Mori K, Nakahara R, Suzuki H, Kasai T, Kamiyama Y et al (2013) Characteristics of subsolid pulmonary nodules showing growth during follow-up with CT scanning. Chest 143(2):436–443
21. Kim EA, Johkoh T, Lee KS, Han J, Fujimoto K, Sadohara J et al (2001) Quantification of ground-glass opacity on high-resolution CT of small peripheral adenocarcinoma of the lung: pathologic and prognostic implications. AJR Am J Roentgenol 177(6):1417–1422
22. Nakamura H, Saji H, Ogata A, Saijo T, Okada S, Kato H (2004) Lung cancer patients showing pure ground-glass opacity on computed tomography are good candidates for wedge resection. Lung Cancer 44(1):61–68
23. Tateishi U, Muller NL, Johkoh T, Maeshima A, Asamura H, Satake M et al (2005) Mucin-producing adenocarcinoma of the lung: thin-section computed tomography findings in 48 patients and their effect on prognosis. J Comput Assist Tomogr 29(3):361–368
24. Fukui T, Katayama T, Ito S, Abe T, Hatooka S, Mitsudomi T (2009) Clinicopathological features of small-sized non-small cell lung cancer with mediastinal lymph node metastasis. Lung Cancer 66(3):309–313
25. Vazquez M, Carter D, Brambilla E, Gazdar A, Noguchi M, Travis WD et al (2009) Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implications. Lung Cancer 64(2):148–154
26. Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M et al (2012) Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study. J Thorac Cardiovasc Surg 143(3):607–612
27. Nakamura S, Fukui T, Taniguchi T, Usami N, Kawaguchi K, Ishiguro F et al (2013) Prognostic impact of tumor size eliminating the ground glass opacity component: modified clinical T descriptors of the tumor, node, metastasis classification of lung cancer. J Thorac Oncol 8(12):1551–1557
28. Gierada DS, Pinsky P, Nath H, Chiles C, Duan F, Aberle DR (2014) Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination. J Natl Cancer Inst. 106(11)
29. Iwata H, Shirahashi K, Mizuno Y, Yamamoto H, Takemura H (2014) Feasibility of segmental resection in non-small-cell lung cancer with ground-glass opacity. Eur J Cardiothorac Surg 46(3):375–379, discussion 9
30. Hattori A, Suzuki K, Takamochi K, Oh S (2015) Clinical features of multiple lung cancers based on thin-section computed tomography: what are the appropriate surgical strategies for second lung cancers? Surg Today 45(2):189–196
31. Kobayashi Y, Sakao Y, Deshpande GA, Fukui T, Mizuno T, Kuroda H et al (2014) The association between baseline clinical-radiological characteristics and growth of pulmonary nodules with ground-glass opacity. Lung Cancer 83(1):61–66
32. Kodama H, Yamakado K, Hasegawa T, Takao M, Taguchi O, Fukai I et al (2014) Radiofrequency ablation for ground-glass opacity-dominant lung adenocarcinoma. J Vasc Interv Radiol 25(3):333–339
33. Nakata M, Sawada S, Saeki H, Takashima S, Mogami H, Teramoto N et al (2003) Prospective study of thoracoscopic limited resection for ground-glass opacity selected by computed tomography. Ann Thorac Surg 75(5):1601–1605, discussion 5-6
34. Henschke CI, Shaham D, Yankelevitz DF, Kramer A, Kostis WJ, Reeves AP et al (2006) CT screening for lung cancer: significance of diagnoses in its baseline cycle. Clin Imaging 30(1):11–15
35. Henschke CI, Yankelevitz DF, Miettinen OS (2006) International Early Lung Cancer Action Program I. Computed tomographic screening for lung cancer: the relationship of disease stage to tumor size. Arch Intern Med 166(3):321–325
36. Kodama K, Higashiyama M, Takami K, Oda K, Okami J, Maeda J et al (2008) Treatment strategy for patients with small peripheral lung lesion(s): intermediate-term results of prospective study. Eur J Cardiothorac Surg 34(5):1068–1074
37. Carretta A, Ciriaco P, Melloni G, Bandiera A, Libretti L, Puglisi A et al (2009) Surgical treatment of multiple primary adenocarcinomas of the lung. Thorac Cardiovasc Surg 57(1):30–34
38. Kohno T, Fujimori S, Kishi K, Fujii T (2010) Safe and effective minimally invasive approaches for small ground glass opacity. Ann Thorac Surg 89(6):S2114–S2117
39. Zhou Q, Suzuki K, Anami Y, Oh S, Takamochi K (2010) Clinicopathologic features in resected subcentimeter lung cancer − status of lymph node metastases. Interact Cardiovasc Thorac Surg 10(1):53–57
40. Matsunaga T, Suzuki K, Hattori A, Fukui M, Kitamura Y, Miyasaka Y et al (2013) Lung cancer with scattered consolidation: detection of new independent radiological category of peripheral lung cancer on thin-section computed tomography. Interact Cardiovasc Thorac Surg 16(4):445–449
41. Ambrosini-Spaltro A, Ruiu A, Seebacher C, Vattemi E, Gentile L, Feil B et al (2014) Impact of the IASLC/ATS/ERS classification in pN0 pulmonary adenocarcinomas: a study with radiological-pathological comparisons and survival analyses. Pathol Res Pract 210(1):40–46
42. Ye B, Cheng M, Ge XX, Geng JF, Li W, Feng J et al (2014) Factors that predict lymph node status in clinical stage T1aN0M0 lung adenocarcinomas. World J Surg Oncol 12:42
43. Ye B, Cheng M, Li W, Ge XX, Geng JF, Feng J et al (2014) Predictive factors for lymph node metastasis in clinical stage IA lung adenocarcinoma. Ann Thorac Surg 98(1):217–223
44. Kudo Y, Matsubayashi J, Saji H, Akata S, Shimada Y, Kato Y et al (2015) Association between high-resolution computed tomography findings and the IASLC/ATS/ERS classification of small lung adenocarcinomas in Japanese patients. Lung Cancer 90(1):47–54
45. Yoshioka M, Ichiguchi O (2009) Selection of sublobar resection for c-stage IA non-small cell lung cancer based on a combination of structural imaging by CT and functional imaging by FDG PET. Ann Thorac Cardiovasc Surg 15(2):82–88
46. Matsuguma H, Yokoi K, Anraku M, Kondo T, Kamiyama Y, Mori K et al (2002) Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: A predictor of lymph node metastasis. J Thorac Cardiovasc Surg 124(2):278–284
47. Matsuguma H, Nakahara R, Anraku M, Kondo T, Tsuura Y, Kamiyama Y et al (2004) Objective definition and measurement method of ground-glass opacity for planning limited resection in patients with clinical stage IA adenocarcinoma of the lung. Eur J Cardiothorac Surg 25(6):1102–1106
48. Sagawa M, Higashi K, Usuda K, Aikawa H, Machida Y, Tanaka M et al (2009) Curative wedge resection for non-invasive bronchioloalveolar carcinoma. Tohoku J Exp Med 217(2):133–137
49. Kim TJ, Park CM, Goo JM, Lee KW (2012) Is there a role for FDG PET in the management of lung cancer manifesting predominantly as ground-glass opacity? AJR Am J Roentgenol 198(1):83–88
50. Seok Y, Cho S, Kim K, Jheon S (2014) Partly solid pulmonary nodules: waiting for change or surgery outright? Interact Cardiovasc Thorac Surg 19(4):556–560
51. Yoshida J, Ishii G, Hishida T, Aokage K, Tsuboi M, Ito H et al (2015) Limited resection trial for pulmonary ground-glass opacity nodules: case selection based on high-resolution computed tomography-interim results. Jpn J Clin Oncol 45(7):677–681
52. Ohta Y, Shimizu Y, Kobayashi T, Matsui O, Minato H, Matsumoto I et al (2006) Pathologic and biological assessment of lung tumors showing ground-glass opacity. Ann Thorac Surg 81(4):1194–1197
53. Suzuki K, Kusumoto M, Watanabe S, Tsuchiya R, Asamura H (2006) Radiologic classification of small adenocarcinoma of the lung: radiologic-pathologic correlation and its prognostic impact. Ann Thorac Surg 81(2):413–419
54. Asamura H, Suzuki K, Watanabe S, Matsuno Y, Maeshima A, Tsuchiya R (2003) A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions. Ann Thorac Surg 76(4):1016–1022
55. Ohde Y, Nagai K, Yoshida J, Nishimura M, Takahashi K, Suzuki K et al (2003) The proportion of consolidation to ground-glass opacity on high resolution CT is a good predictor for distinguishing the population of non-invasive peripheral adenocarcinoma. Lung Cancer 42(3):303–310
56. Aokage K, Yoshida J, Ishii G, Matsumura Y, Haruki T, Hishida T et al (2013) Identification of early t1b lung adenocarcinoma based on thin-section computed tomography findings. J Thorac Oncol 8(10):1289–1294
57. Duann CW, Hung JJ, Hsu PK, Huang CS, Hsieh CC, Hsu HS et al (2013) Surgical outcomes in lung cancer presenting as ground-glass opacities of 3 cm or less: a review of 5 years' experience. J Chin Med Assoc 76(12):693–697
58. Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M et al (2014) Segmentectomy for clinical stage IA lung adenocarcinoma showing solid dominance on radiology. Eur J Cardiothorac Surg 46(4):637–642
59. Yanagawa M, Tanaka Y, Leung AN, Morii E, Kusumoto M, Watanabe S et al (2014) Prognostic importance of volumetric measurements in stage I lung adenocarcinoma. Radiology 272(2):557–567
60. Cho JH, Choi YS, Kim J, Kim HK, Zo JI, Shim YM (2015) Long-term outcomes of wedge resection for pulmonary ground-glass opacity nodules. Ann Thorac Surg 99(1):218–222
61. Hattori A, Suzuki K, Matsunaga T, Miyasaka Y, Takamochi K, Oh S (2015) What is the appropriate operative strategy for radiologically solid tumours in subcentimetre lung cancer patients?dagger. Eur J Cardiothorac Surg 47(2):244–249
62. Li Z, Ye B, Bao M, Xu B, Chen Q, Liu S et al (2015) Radiologic predictors for clinical stage IA lung adenocarcinoma with ground glass components: a multi-center study of long-term outcomes. PLoS One 10(9), e0136616
63. Nakamura S, Fukui T, Kawaguchi K, Fukumoto K, Hirakawa A, Yokoi K (2015) Does ground glass opacity-dominant feature have a prognostic significance even in clinical T2aN0M0 lung adenocarcinoma? Lung Cancer 89(1):38–42
64. Sakurai H, Nakagawa K, Watanabe S, Asamura H (2015) Clinicopathologic features of resected subcentimeter lung cancer. Ann Thorac Surg 99(5):1731–1738
65. Yano M, Yoshida J, Koike T, Kameyama K, Shimamoto A, Nishio W et al (2015) Survival of 1737 lobectomy-tolerable patients who underwent limited resection for cStage IA non-small-cell lung cancer. Eur J Cardiothorac Surg 47(1):135–142
66. Kodama K, Higashiyama M, Yokouchi H, Takami K, Kuriyama K, Mano M et al (2001) Prognostic value of ground-glass opacity found in small lung adenocarcinoma on high-resolution CT scanning. Lung Cancer 33(1):17–25
67. Aoki T, Tomoda Y, Watanabe H, Nakata H, Kasai T, Hashimoto H et al (2001) Peripheral lung adenocarcinoma: correlation of thin-section CT findings with histologic prognostic factors and survival. Radiology 220(3):803–809
68. Takashima S, Maruyama Y, Hasegawa M, Saito A, Haniuda M, Kadoya M (2003) High-resolution CT features: prognostic significance in peripheral lung adenocarcinoma with bronchioloalveolar carcinoma components. Respiration 70(1):36–42
69. Ikeda N, Maeda J, Yashima K, Tsuboi M, Kato H, Akada S et al (2004) A clinicopathological study of resected adenocarcinoma 2 cm or less in diameter. Ann Thorac Surg 78(3):1011–1016
70. Sakao Y, Nakazono T, Sakuragi T, Natsuaki M, Itoh T (2004) Predictive factors for survival in surgically resected clinical IA peripheral adenocarcinoma of the lung. Ann Thorac Surg 77(4):1157–1161, discussion 61-2
71. Seki N, Sawada S, Nakata M, Inoue T, Nishimura R, Segawa Y et al (2008) Lung cancer with localized ground-glass attenuation represents early-stage adenocarcinoma in nonsmokers. J Thorac Oncol 3(5):483–490
72. Higashi K, Sakuma T, Ito K, Niho S, Ueda Y, Kobayashi T et al (2009) Combined evaluation of preoperative FDG uptake on PET, ground-glass opacity area on CT, and serum CEA level: identification of both low and high risk of recurrence in patients with resected T1 lung adenocarcinoma. Eur J Nucl Med Mol Imaging 36(3):373–381
73. Inoue M, Minami M, Sawabata N, Utsumi T, Kadota Y, Shigemura N et al (2010) Clinical outcome of resected solid-type small-sized c-stage IA non-small cell lung cancer. Eur J Cardiothorac Surg 37(6):1445–1449
74. Shi CL, Zhang XY, Han BH, He WZ, Shen J, Chu TQ (2011) A clinicopathological study of resected non-small cell lung cancers 2 cm or less in diameter: a prognostic assessment. Med Oncol 28(4):1441–1446
75. Lederlin M, Puderbach M, Muley T, Schnabel PA, Stenzinger A, Kauczor HU et al (2013) Correlation of radio- and histomorphological pattern of pulmonary adenocarcinoma. Eur Respir J 41(4):943–951
76. Matsuguma H, Oki I, Nakahara R, Suzuki H, Kasai T, Kamiyama Y et al (2013) Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer. Ann Thorac Surg 95(6):1878–1884
77. Shiono S, Yanagawa N, Abiko M, Sato T (2014) Detection of non-aggressive stage IA lung cancer using chest computed tomography and positron emission tomography/computed tomography. Interact Cardiovasc Thorac Surg 19(4):637–643
78. Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M et al (2014) Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy. Chest 145(1):66–71
79. Hwang EJ, Park CM, Ryu Y, Lee SM, Kim YT, Kim YW et al (2015) Pulmonary adenocarcinomas appearing as part-solid ground-glass nodules: is measuring solid component size a better prognostic indicator? Eur Radiol 25(2):558–567
80. Kakinuma R, Kodama K, Yamada K, Yokoyama A, Adachi S, Mori K et al (2008) Performance evaluation of 4 measuring methods of ground-glass opacities for predicting the 5-year relapse-free survival of patients with peripheral nonsmall cell lung cancer: a multicenter study. J Comput Assist Tomogr 32(5):792–798
81. Okada M, Nakayama H, Okumura S, Daisaki H, Adachi S, Yoshimura M et al (2011) Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma. J Thorac Cardiovasc Surg 141(6):1384–1391
82. Dong B, Sato M, Sagawa M, Endo C, Usuda K, Sakurada A et al (2002) Computed tomographic image comparison between mediastinal and lung windows provides possible prognostic information in patients with small peripheral lung adenocarcinoma. J Thorac Cardiovasc Surg 124(5):1014–1020
83. Murakawa T, Konoeda C, Ito T, Inoue Y, Sano A, Nagayama K et al (2013) The ground glass opacity component can be eliminated from the T-factor assessment of lung adenocarcinoma. Eur J Cardiothorac Surg 43(5):925–932
84. Hashizume T, Yamada K, Okamoto N, Saito H, Oshita F, Kato Y et al (2008) Prognostic significance of thin-section CT scan findings in small-sized lung adenocarcinoma. Chest 133(2):441–447
85. Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS (2006) Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 1763–1771. United States: 2006 Massachusetts Medical Society
86. Henschke CI, Yankelevitz DF, Yip R, Reeves AP, Farooqi A, Xu D et al (2012) Lung cancers diagnosed at annual CT screening: volume doubling times. Radiology 263(2):578–583
87. Network NCC. Clinical Practice Guidelines in Oncology (NCCN Guidelines). Version 1.2014 Lung Cancer Screening. http://www.nccn.org/professionals/physician_gls/pdf/lung_screening.pdf. Accessed March 27, 2015
88. Higashiyama M, Kodama K, Yokouchi H, Takami K, Mano M, Kido S et al (1999) Prognostic value of bronchiolo-alveolar carcinoma component of small lung adenocarcinoma. Ann Thorac Surg 68(6):2069–2073
89. International Early Lung Cancer Action Program Protocol http://www.ielcap.org/sites/default/files/I-ELCAP%20protocol-v21-3-1-14.pdf. Accessed May 30, 2017
90. Henschke C, Yankelevitz D, Naidich D, McCauley D, McGuinness G, Libby D et al (2004) CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans. Radiology 231(1):164–168
91. Henschke C, Yip R, Yankelevitz D, Smith J (2013) Definition of a positive test result in computed tomography screening for lung cancer: a cohort study. Ann Intern Med 158(4):246–252
92. Yip R, Henschke C, Yankelevitz D, Boffetta P, Smith J (2015) The International Early Lung Cancer Investigators. The impact of the regimen of screening on lung cancer cure: a comparison of I-ELCAP and NLST. Eur J Cancer Prev 24(3):201–208
93. Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR et al (2016) NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 4.2016. J Natl Compr Canc Netw 14(3):255–264
94. Pinsky PF, Gierada DS, Black W, Munden R, Nath H, Aberle D et al (2015) Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment. Ann Intern Med 162(7):485–491
95. Kazerooni E, Austin J, Black W, Dyer D, Hazelton T, Leung A et al (2014) ACR-STR practice parameter for the performance and reporting of lung cancer screening thoracic computed tomography. J Thorac Imaging 29(5):310–316
96. American College of Radiology. http://www.acr.org/Quality-Safety/Resources/LungRADS. Accessed May 30, 2017